{
    "clinical_study": {
        "@rank": "16568", 
        "arm_group": [
            {
                "arm_group_label": "Fermented red ginseng", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This study was conducted to investigate the effects of daily supplementation of fermented\n      red ginseng (FRG) on glycemic status in subjects with impaired fasting glucose (IFG) or type\n      2 diabetes."
        }, 
        "brief_title": "Hypoglycemic Effects of Fermented Red Ginseng in Subject With Impaired Fasting Glucose or Type 2 Diabetes", 
        "condition": "Impaired Glucose or Type 2 Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study was a 4 weeks, randomized, double-blind, placebo-controlled trial. Forty-two\n      subjects with IFG or type 2 diabetes were randomly allocated to 2 groups to consume placebo\n      or FRG three times per day for 4 weeks. Fasting and postprandial glucose profiles during\n      meal tolerance test were assessed before and after the intervention."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 20-75 years with fasting glucose 100~140 mg/dL at least two of the  following\n\n        Exclusion Criteria:\n\n          -  Lipid metabolic disorder\n\n          -  Acute or chronic inflammatory disease\n\n          -  Taking medication of corticosteroid within 4 weeks of the study\n\n          -  Cardiovascular disease (arrhythmia, heart failure, myocardial infarction or patient\n             with pacemaker)\n\n          -  Allergic or hypersensitive to any of the ingredients in the test products\n\n          -  Participation in other clinical trials within 2 months\n\n          -  Abnormal hepatic liver function or renal disease (acute/chronic renal failure or\n             nephrotic syndrome)\n\n          -  Taking medication of lipid phosphates within 3 months of the study etc,"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "42", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01826409", 
            "org_study_id": "WKP-FG7070-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Fermented red ginseng", 
                "description": "Fermented red ginseng 2.7g/day for 4 weeks", 
                "intervention_name": "Fermented Red Ginseng", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo 2.7g/day for 4 weeks", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 28, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jeonju", 
                    "country": "Korea, Republic of", 
                    "state": "Jeollabok-do", 
                    "zip": "560-822"
                }, 
                "name": "Clincial Trial Center for Functional Foods"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_official": {
            "affiliation": "Chonbuk National University Hospital", 
            "last_name": "Tae Sun Park, MD., PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "September 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Fasting and postprandial glucose profiles during meal tolerance test were assessed before(baseline) and after the intervention", 
            "measure": "Glucose profiles during meal tolerance test", 
            "safety_issue": "Yes", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01826409"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chonbuk National University Hospital", 
            "investigator_full_name": "Soo-Wan Chae", 
            "investigator_title": "Principal Investigator, Clinical Trial Center for Functional Foods", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Change in lipid profiles were assessed before(baseline) and after the intervention", 
            "measure": "Change in lipid profiles", 
            "safety_issue": "Yes", 
            "time_frame": "4 weeks"
        }, 
        "source": "Chonbuk National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chonbuk National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}